Vident Investment Advisory’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,270
Closed -$1.56M 1298
2022
Q3
$1.56M Buy
33,270
+2,369
+8% +$131K 0.05% 441
2022
Q2
$1.82M Buy
30,901
+2,346
+8% +$129K 0.05% 429
2022
Q1
$1.51M Buy
28,555
+333
+1% +$19.2K 0.04% 550
2021
Q4
$1.71M Buy
28,222
+1,183
+4% +$70.2K 0.04% 515
2021
Q3
$1.52M Sell
27,039
-4,935
-15% -$271K 0.05% 547
2021
Q2
$1.67M Sell
31,974
-978
-3% -$47K 0.05% 477
2021
Q1
$1.45M Sell
32,952
-5,140
-13% -$216K 0.05% 506
2020
Q4
$1.33M Sell
38,092
-2,223
-6% -$78.9K 0.05% 451
2020
Q3
$1.47M Sell
40,315
-3,568
-8% -$133K 0.07% 373
2020
Q2
$1.65M Sell
43,883
-6,885
-14% -$275K 0.09% 268
2020
Q1
$1.86M Sell
50,768
-18,061
-26% -$701K 0.12% 188
2019
Q4
$2.79M Buy
+68,829
New +$2.57M 0.17% 136
2015
Q4
Sell
-9,612
Closed -$434K 714
2015
Q3
$434K Buy
+9,612
New +$454K 0.06% 591

Other funds holding PBH

Vident Investment Advisory's PBH Position: Q4 2022 in Review

Vident Investment Advisory sold out of Prestige Consumer Healthcare (PBH) in Q4 2022, closing a stake of 33,270 shares — an estimated $1.56M sold.

Vident Investment Advisory first reported a position in PBH in Q3 2015 and held it in 13 quarters. The position peaked at $2.79M in Q4 2019. 289 funds tracked by Wall St. Rank hold PBH as of Q4 2022.

  • Vident Investment Advisory reported no remaining Prestige Consumer Healthcare position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 33,270 Prestige Consumer Healthcare shares in Q4 2022, an estimated $1.56M.
  • Vident Investment Advisory first reported a position in Prestige Consumer Healthcare in Q3 2015 and held it in 13 quarters.
  • Vident Investment Advisory's Prestige Consumer Healthcare position peaked at $2.79M in Q4 2019.
  • 289 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.